nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Bacitracin—IDE—type 2 diabetes mellitus	0.0172	0.965	CrCbGaD
Terlipressin—Hyponatraemia—Glimepiride—type 2 diabetes mellitus	0.00301	0.00582	CcSEcCtD
Terlipressin—Ventricular fibrillation—Losartan—type 2 diabetes mellitus	0.00297	0.00574	CcSEcCtD
Terlipressin—Acute coronary syndrome—Repaglinide—type 2 diabetes mellitus	0.00295	0.0057	CcSEcCtD
Terlipressin—Myocardial infarction—Repaglinide—type 2 diabetes mellitus	0.00294	0.00567	CcSEcCtD
Terlipressin—Angiopathy—Acarbose—type 2 diabetes mellitus	0.00292	0.00565	CcSEcCtD
Terlipressin—Malnutrition—Linagliptin—type 2 diabetes mellitus	0.00289	0.00558	CcSEcCtD
Terlipressin—Acute coronary syndrome—Rosiglitazone—type 2 diabetes mellitus	0.00279	0.00539	CcSEcCtD
Terlipressin—Myocardial infarction—Rosiglitazone—type 2 diabetes mellitus	0.00277	0.00536	CcSEcCtD
Terlipressin—Malnutrition—Nateglinide—type 2 diabetes mellitus	0.0027	0.00522	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Miglitol—type 2 diabetes mellitus	0.00251	0.00486	CcSEcCtD
Terlipressin—Cardiac disorder—Repaglinide—type 2 diabetes mellitus	0.0025	0.00482	CcSEcCtD
Terlipressin—Hyponatraemia—Glyburide—type 2 diabetes mellitus	0.00248	0.0048	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Linagliptin—type 2 diabetes mellitus	0.00244	0.00472	CcSEcCtD
Terlipressin—Cardiac disorder—Rosiglitazone—type 2 diabetes mellitus	0.00236	0.00456	CcSEcCtD
Terlipressin—Malnutrition—Repaglinide—type 2 diabetes mellitus	0.00234	0.00452	CcSEcCtD
Terlipressin—Acute coronary syndrome—Pioglitazone—type 2 diabetes mellitus	0.00234	0.00452	CcSEcCtD
Terlipressin—Myocardial infarction—Pioglitazone—type 2 diabetes mellitus	0.00233	0.0045	CcSEcCtD
Terlipressin—Abdominal pain—Miglitol—type 2 diabetes mellitus	0.0023	0.00445	CcSEcCtD
Terlipressin—Skin disorder—Linagliptin—type 2 diabetes mellitus	0.00229	0.00442	CcSEcCtD
Terlipressin—Cardiac failure—Gliclazide—type 2 diabetes mellitus	0.00228	0.0044	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Tolbutamide—type 2 diabetes mellitus	0.00226	0.00437	CcSEcCtD
Terlipressin—Hyponatraemia—Gliclazide—type 2 diabetes mellitus	0.00223	0.00431	CcSEcCtD
Terlipressin—Malnutrition—Rosiglitazone—type 2 diabetes mellitus	0.00221	0.00427	CcSEcCtD
Terlipressin—Skin exfoliation—Losartan—type 2 diabetes mellitus	0.00217	0.0042	CcSEcCtD
Terlipressin—Atrial fibrillation—Valsartan—type 2 diabetes mellitus	0.00215	0.00416	CcSEcCtD
Terlipressin—Pulmonary oedema—Irbesartan—type 2 diabetes mellitus	0.00215	0.00416	CcSEcCtD
Terlipressin—Menopausal symptoms—Orlistat—type 2 diabetes mellitus	0.00214	0.00413	CcSEcCtD
Terlipressin—Bradycardia—Glimepiride—type 2 diabetes mellitus	0.00211	0.00408	CcSEcCtD
Terlipressin—Cardiac failure—Valsartan—type 2 diabetes mellitus	0.00209	0.00404	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Chlorpropamide—type 2 diabetes mellitus	0.00206	0.00397	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Tolazamide—type 2 diabetes mellitus	0.00206	0.00397	CcSEcCtD
Terlipressin—Acute coronary syndrome—Bromocriptine—type 2 diabetes mellitus	0.00206	0.00397	CcSEcCtD
Terlipressin—Hyponatraemia—Valsartan—type 2 diabetes mellitus	0.00205	0.00396	CcSEcCtD
Terlipressin—Myocardial infarction—Bromocriptine—type 2 diabetes mellitus	0.00205	0.00395	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Linagliptin—type 2 diabetes mellitus	0.00204	0.00393	CcSEcCtD
Terlipressin—Pulmonary oedema—Losartan—type 2 diabetes mellitus	0.00202	0.00391	CcSEcCtD
Terlipressin—Hypertension—Repaglinide—type 2 diabetes mellitus	0.00202	0.0039	CcSEcCtD
Terlipressin—Chest pain—Repaglinide—type 2 diabetes mellitus	0.00199	0.00385	CcSEcCtD
Terlipressin—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.00199	0.00385	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Repaglinide—type 2 diabetes mellitus	0.00198	0.00382	CcSEcCtD
Terlipressin—Cardiac disorder—Pioglitazone—type 2 diabetes mellitus	0.00198	0.00382	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Acarbose—type 2 diabetes mellitus	0.00198	0.00382	CcSEcCtD
Terlipressin—Cardiac disorder—Sitagliptin—type 2 diabetes mellitus	0.00192	0.00371	CcSEcCtD
Terlipressin—Hypertension—Rosiglitazone—type 2 diabetes mellitus	0.00191	0.00369	CcSEcCtD
Terlipressin—Bradycardia—Bromocriptine—type 2 diabetes mellitus	0.00191	0.00368	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Nateglinide—type 2 diabetes mellitus	0.00191	0.00368	CcSEcCtD
Terlipressin—Angiopathy—Sitagliptin—type 2 diabetes mellitus	0.00188	0.00363	CcSEcCtD
Terlipressin—Hot flush—Irbesartan—type 2 diabetes mellitus	0.00188	0.00362	CcSEcCtD
Terlipressin—Menopausal symptoms—Irbesartan—type 2 diabetes mellitus	0.00186	0.00359	CcSEcCtD
Terlipressin—Skin disorder—Repaglinide—type 2 diabetes mellitus	0.00186	0.00358	CcSEcCtD
Terlipressin—Malnutrition—Pioglitazone—type 2 diabetes mellitus	0.00186	0.00358	CcSEcCtD
Terlipressin—Abdominal pain—Acarbose—type 2 diabetes mellitus	0.00181	0.0035	CcSEcCtD
Terlipressin—Malnutrition—Glimepiride—type 2 diabetes mellitus	0.00181	0.00349	CcSEcCtD
Terlipressin—Malnutrition—Sitagliptin—type 2 diabetes mellitus	0.0018	0.00348	CcSEcCtD
Terlipressin—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.00177	0.00342	CcSEcCtD
Terlipressin—Hyponatraemia—Irbesartan—type 2 diabetes mellitus	0.00176	0.0034	CcSEcCtD
Terlipressin—Abdominal pain—Nateglinide—type 2 diabetes mellitus	0.00174	0.00337	CcSEcCtD
Terlipressin—Atrial fibrillation—Losartan—type 2 diabetes mellitus	0.00174	0.00337	CcSEcCtD
Terlipressin—Cardiac disorder—Bromocriptine—type 2 diabetes mellitus	0.00174	0.00336	CcSEcCtD
Terlipressin—Nausea—Miglitol—type 2 diabetes mellitus	0.00173	0.00334	CcSEcCtD
Terlipressin—Angiopathy—Bromocriptine—type 2 diabetes mellitus	0.0017	0.00328	CcSEcCtD
Terlipressin—Acute coronary syndrome—Gliclazide—type 2 diabetes mellitus	0.00169	0.00326	CcSEcCtD
Terlipressin—Myocardial infarction—Gliclazide—type 2 diabetes mellitus	0.00168	0.00324	CcSEcCtD
Terlipressin—Hypertension—Glipizide—type 2 diabetes mellitus	0.00167	0.00323	CcSEcCtD
Terlipressin—Hyponatraemia—Losartan—type 2 diabetes mellitus	0.00166	0.0032	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	0.00165	0.00319	CcSEcCtD
Terlipressin—Headache—Tolbutamide—type 2 diabetes mellitus	0.00164	0.00317	CcSEcCtD
Terlipressin—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00163	0.00315	CcSEcCtD
Terlipressin—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00161	0.00312	CcSEcCtD
Terlipressin—Hypertension—Pioglitazone—type 2 diabetes mellitus	0.0016	0.00309	CcSEcCtD
Terlipressin—Chest pain—Pioglitazone—type 2 diabetes mellitus	0.00158	0.00305	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.00157	0.00303	CcSEcCtD
Terlipressin—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.00157	0.00303	CcSEcCtD
Terlipressin—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.00157	0.00302	CcSEcCtD
Terlipressin—Hypertension—Glimepiride—type 2 diabetes mellitus	0.00156	0.00301	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.00156	0.00301	CcSEcCtD
Terlipressin—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00156	0.003	CcSEcCtD
Terlipressin—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.00156	0.003	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.00152	0.00294	CcSEcCtD
Terlipressin—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00151	0.00293	CcSEcCtD
Terlipressin—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.00151	0.00292	CcSEcCtD
Terlipressin—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00151	0.00292	CcSEcCtD
Terlipressin—Atrial fibrillation—Ramipril—type 2 diabetes mellitus	0.00149	0.00289	CcSEcCtD
Terlipressin—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00149	0.00288	CcSEcCtD
Terlipressin—Headache—Tolazamide—type 2 diabetes mellitus	0.00149	0.00288	CcSEcCtD
Terlipressin—Malnutrition—Glyburide—type 2 diabetes mellitus	0.00149	0.00288	CcSEcCtD
Terlipressin—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.00148	0.00287	CcSEcCtD
Terlipressin—Headache—Linagliptin—type 2 diabetes mellitus	0.00148	0.00285	CcSEcCtD
Terlipressin—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.00147	0.00284	CcSEcCtD
Terlipressin—Vomiting—Acarbose—type 2 diabetes mellitus	0.00146	0.00281	CcSEcCtD
Terlipressin—Cardiac failure—Ramipril—type 2 diabetes mellitus	0.00145	0.0028	CcSEcCtD
Terlipressin—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.00144	0.00279	CcSEcCtD
Terlipressin—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.00144	0.00278	CcSEcCtD
Terlipressin—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.00143	0.00276	CcSEcCtD
Terlipressin—Hyponatraemia—Ramipril—type 2 diabetes mellitus	0.00142	0.00275	CcSEcCtD
Terlipressin—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00142	0.00273	CcSEcCtD
Terlipressin—Nausea—Tolazamide—type 2 diabetes mellitus	0.00142	0.00273	CcSEcCtD
Terlipressin—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.00141	0.00272	CcSEcCtD
Terlipressin—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.00141	0.00272	CcSEcCtD
Terlipressin—Vomiting—Nateglinide—type 2 diabetes mellitus	0.0014	0.00271	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.00138	0.00266	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.00136	0.00264	CcSEcCtD
Terlipressin—Nausea—Acarbose—type 2 diabetes mellitus	0.00136	0.00263	CcSEcCtD
Terlipressin—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.00135	0.00261	CcSEcCtD
Terlipressin—Malnutrition—Gliclazide—type 2 diabetes mellitus	0.00134	0.00259	CcSEcCtD
Terlipressin—Acute coronary syndrome—Irbesartan—type 2 diabetes mellitus	0.00133	0.00257	CcSEcCtD
Terlipressin—Myocardial infarction—Irbesartan—type 2 diabetes mellitus	0.00133	0.00256	CcSEcCtD
Terlipressin—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.00131	0.00254	CcSEcCtD
Terlipressin—Nausea—Nateglinide—type 2 diabetes mellitus	0.00131	0.00253	CcSEcCtD
Terlipressin—Cardiac disorder—Valsartan—type 2 diabetes mellitus	0.00131	0.00253	CcSEcCtD
Terlipressin—Bradycardia—Metformin—type 2 diabetes mellitus	0.00131	0.00253	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.00131	0.00253	CcSEcCtD
Terlipressin—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00131	0.00252	CcSEcCtD
Terlipressin—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.0013	0.00252	CcSEcCtD
Terlipressin—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.0013	0.00251	CcSEcCtD
Terlipressin—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.00129	0.0025	CcSEcCtD
Terlipressin—Angiopathy—Valsartan—type 2 diabetes mellitus	0.00128	0.00248	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.00127	0.00246	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00127	0.00245	CcSEcCtD
Terlipressin—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00125	0.00241	CcSEcCtD
Terlipressin—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.00124	0.00239	CcSEcCtD
Terlipressin—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00124	0.00239	CcSEcCtD
Terlipressin—Malnutrition—Valsartan—type 2 diabetes mellitus	0.00123	0.00238	CcSEcCtD
Terlipressin—Malnutrition—Orlistat—type 2 diabetes mellitus	0.00121	0.00235	CcSEcCtD
Terlipressin—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00121	0.00235	CcSEcCtD
Terlipressin—Headache—Repaglinide—type 2 diabetes mellitus	0.0012	0.00231	CcSEcCtD
Terlipressin—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.00119	0.00231	CcSEcCtD
Terlipressin—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00119	0.0023	CcSEcCtD
Terlipressin—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.00119	0.00229	CcSEcCtD
Terlipressin—Angiopathy—Metformin—type 2 diabetes mellitus	0.00117	0.00225	CcSEcCtD
Terlipressin—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00117	0.00225	CcSEcCtD
Terlipressin—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00116	0.00225	CcSEcCtD
Terlipressin—Hypertension—Gliclazide—type 2 diabetes mellitus	0.00116	0.00223	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00115	0.00222	CcSEcCtD
Terlipressin—Chest pain—Gliclazide—type 2 diabetes mellitus	0.00114	0.0022	CcSEcCtD
Terlipressin—Nausea—Repaglinide—type 2 diabetes mellitus	0.00113	0.00219	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00113	0.00219	CcSEcCtD
Terlipressin—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00113	0.00218	CcSEcCtD
Terlipressin—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.00113	0.00218	CcSEcCtD
Terlipressin—Malnutrition—Metformin—type 2 diabetes mellitus	0.00112	0.00216	CcSEcCtD
Terlipressin—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.0011	0.00213	CcSEcCtD
Terlipressin—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.00108	0.00209	CcSEcCtD
Terlipressin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00108	0.00209	CcSEcCtD
Terlipressin—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.00108	0.00208	CcSEcCtD
Terlipressin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00107	0.00207	CcSEcCtD
Terlipressin—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00107	0.00207	CcSEcCtD
Terlipressin—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.00107	0.00207	CcSEcCtD
Terlipressin—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00107	0.00206	CcSEcCtD
Terlipressin—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.00106	0.00205	CcSEcCtD
Terlipressin—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.00106	0.00204	CcSEcCtD
Terlipressin—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00105	0.00203	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.00105	0.00203	CcSEcCtD
Terlipressin—Chest pain—Valsartan—type 2 diabetes mellitus	0.00105	0.00202	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00104	0.00201	CcSEcCtD
Terlipressin—Angiopathy—Losartan—type 2 diabetes mellitus	0.00104	0.002	CcSEcCtD
Terlipressin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00104	0.002	CcSEcCtD
Terlipressin—Chest pain—Orlistat—type 2 diabetes mellitus	0.00103	0.002	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00103	0.00198	CcSEcCtD
Terlipressin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00101	0.00195	CcSEcCtD
Terlipressin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00101	0.00194	CcSEcCtD
Terlipressin—Vomiting—Glipizide—type 2 diabetes mellitus	0.001	0.00194	CcSEcCtD
Terlipressin—Headache—Glipizide—type 2 diabetes mellitus	0.00099	0.00191	CcSEcCtD
Terlipressin—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000984	0.0019	CcSEcCtD
Terlipressin—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000975	0.00188	CcSEcCtD
Terlipressin—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000974	0.00188	CcSEcCtD
Terlipressin—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000972	0.00188	CcSEcCtD
Terlipressin—Hypertension—Metformin—type 2 diabetes mellitus	0.000967	0.00187	CcSEcCtD
Terlipressin—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000963	0.00186	CcSEcCtD
Terlipressin—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000962	0.00186	CcSEcCtD
Terlipressin—Chest pain—Metformin—type 2 diabetes mellitus	0.000953	0.00184	CcSEcCtD
Terlipressin—Headache—Pioglitazone—type 2 diabetes mellitus	0.000949	0.00183	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000947	0.00183	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000943	0.00182	CcSEcCtD
Terlipressin—Nausea—Glipizide—type 2 diabetes mellitus	0.000939	0.00181	CcSEcCtD
Terlipressin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000938	0.00181	CcSEcCtD
Terlipressin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000935	0.00181	CcSEcCtD
Terlipressin—Headache—Glimepiride—type 2 diabetes mellitus	0.000924	0.00178	CcSEcCtD
Terlipressin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000921	0.00178	CcSEcCtD
Terlipressin—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000912	0.00176	CcSEcCtD
Terlipressin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00091	0.00176	CcSEcCtD
Terlipressin—Chest pain—Irbesartan—type 2 diabetes mellitus	0.0009	0.00174	CcSEcCtD
Terlipressin—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000896	0.00173	CcSEcCtD
Terlipressin—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000895	0.00173	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000893	0.00173	CcSEcCtD
Terlipressin—Skin disorder—Metformin—type 2 diabetes mellitus	0.000888	0.00171	CcSEcCtD
Terlipressin—Nausea—Glimepiride—type 2 diabetes mellitus	0.000876	0.00169	CcSEcCtD
Terlipressin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000873	0.00169	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000866	0.00167	CcSEcCtD
Terlipressin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000863	0.00167	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000856	0.00165	CcSEcCtD
Terlipressin—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000853	0.00165	CcSEcCtD
Terlipressin—Chest pain—Losartan—type 2 diabetes mellitus	0.000847	0.00164	CcSEcCtD
Terlipressin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000846	0.00163	CcSEcCtD
Terlipressin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000846	0.00163	CcSEcCtD
Terlipressin—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000842	0.00163	CcSEcCtD
Terlipressin—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000838	0.00162	CcSEcCtD
Terlipressin—Headache—Bromocriptine—type 2 diabetes mellitus	0.000834	0.00161	CcSEcCtD
Terlipressin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000832	0.00161	CcSEcCtD
Terlipressin—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000815	0.00157	CcSEcCtD
Terlipressin—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000796	0.00154	CcSEcCtD
Terlipressin—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000793	0.00153	CcSEcCtD
Terlipressin—Tachycardia—Losartan—type 2 diabetes mellitus	0.000792	0.00153	CcSEcCtD
Terlipressin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00079	0.00153	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000789	0.00152	CcSEcCtD
Terlipressin—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000784	0.00151	CcSEcCtD
Terlipressin—Vomiting—Glyburide—type 2 diabetes mellitus	0.000773	0.00149	CcSEcCtD
Terlipressin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000769	0.00149	CcSEcCtD
Terlipressin—Headache—Glyburide—type 2 diabetes mellitus	0.000762	0.00147	CcSEcCtD
Terlipressin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000747	0.00144	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000745	0.00144	CcSEcCtD
Terlipressin—Chest pain—Ramipril—type 2 diabetes mellitus	0.000726	0.0014	CcSEcCtD
Terlipressin—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000724	0.0014	CcSEcCtD
Terlipressin—Nausea—Glyburide—type 2 diabetes mellitus	0.000723	0.0014	CcSEcCtD
Terlipressin—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000722	0.0014	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000721	0.00139	CcSEcCtD
Terlipressin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000694	0.00134	CcSEcCtD
Terlipressin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000687	0.00133	CcSEcCtD
Terlipressin—Headache—Gliclazide—type 2 diabetes mellitus	0.000684	0.00132	CcSEcCtD
Terlipressin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000682	0.00132	CcSEcCtD
Terlipressin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000682	0.00132	CcSEcCtD
Terlipressin—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000679	0.00131	CcSEcCtD
Terlipressin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000678	0.00131	CcSEcCtD
Terlipressin—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000676	0.00131	CcSEcCtD
Terlipressin—Nausea—Gliclazide—type 2 diabetes mellitus	0.000649	0.00125	CcSEcCtD
Terlipressin—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000642	0.00124	CcSEcCtD
Terlipressin—Vomiting—Valsartan—type 2 diabetes mellitus	0.000638	0.00123	CcSEcCtD
Terlipressin—Vomiting—Orlistat—type 2 diabetes mellitus	0.00063	0.00122	CcSEcCtD
Terlipressin—Headache—Valsartan—type 2 diabetes mellitus	0.000629	0.00121	CcSEcCtD
Terlipressin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000625	0.00121	CcSEcCtD
Terlipressin—Headache—Orlistat—type 2 diabetes mellitus	0.000621	0.0012	CcSEcCtD
Terlipressin—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.00062	0.0012	CcSEcCtD
Terlipressin—Desmopressin—PTGS2—type 2 diabetes mellitus	0.000615	0.0345	CrCbGaD
Terlipressin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000601	0.00116	CcSEcCtD
Terlipressin—Nausea—Valsartan—type 2 diabetes mellitus	0.000596	0.00115	CcSEcCtD
Terlipressin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00059	0.00114	CcSEcCtD
Terlipressin—Nausea—Orlistat—type 2 diabetes mellitus	0.000589	0.00114	CcSEcCtD
Terlipressin—Vomiting—Metformin—type 2 diabetes mellitus	0.000581	0.00112	CcSEcCtD
Terlipressin—Headache—Metformin—type 2 diabetes mellitus	0.000572	0.00111	CcSEcCtD
Terlipressin—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000555	0.00107	CcSEcCtD
Terlipressin—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00055	0.00106	CcSEcCtD
Terlipressin—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000548	0.00106	CcSEcCtD
Terlipressin—Nausea—Metformin—type 2 diabetes mellitus	0.000543	0.00105	CcSEcCtD
Terlipressin—Headache—Irbesartan—type 2 diabetes mellitus	0.00054	0.00104	CcSEcCtD
Terlipressin—Vomiting—Losartan—type 2 diabetes mellitus	0.000516	0.000997	CcSEcCtD
Terlipressin—Nausea—Irbesartan—type 2 diabetes mellitus	0.000512	0.00099	CcSEcCtD
Terlipressin—Headache—Losartan—type 2 diabetes mellitus	0.000508	0.000982	CcSEcCtD
Terlipressin—Nausea—Losartan—type 2 diabetes mellitus	0.000482	0.000931	CcSEcCtD
Terlipressin—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000476	0.00092	CcSEcCtD
Terlipressin—Vomiting—Ramipril—type 2 diabetes mellitus	0.000442	0.000855	CcSEcCtD
Terlipressin—Headache—Ramipril—type 2 diabetes mellitus	0.000436	0.000842	CcSEcCtD
Terlipressin—Nausea—Ramipril—type 2 diabetes mellitus	0.000413	0.000799	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000202	0.000435	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000202	0.000435	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000202	0.000434	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000202	0.000434	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.0002	0.000431	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000199	0.000428	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000199	0.000428	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000198	0.000426	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000198	0.000426	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000197	0.000425	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000195	0.000421	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.00019	0.000409	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000189	0.000407	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000188	0.000404	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000187	0.000403	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000186	0.000401	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000186	0.0004	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000186	0.0004	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000184	0.000397	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000184	0.000397	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000184	0.000396	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000183	0.000394	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000183	0.000394	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000182	0.000391	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000181	0.00039	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000181	0.00039	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000181	0.00039	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000181	0.00039	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000181	0.000389	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000181	0.000389	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	0.00018	0.000388	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.00018	0.000387	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.00018	0.000387	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.00018	0.000387	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000179	0.000386	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000179	0.000386	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000178	0.000384	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000178	0.000383	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000178	0.000383	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000177	0.000382	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000177	0.000381	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000172	0.00037	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.00017	0.000367	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000169	0.000365	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000169	0.000364	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000168	0.000361	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000166	0.000358	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000166	0.000358	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000165	0.000356	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000164	0.000353	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	0.000164	0.000353	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000163	0.000351	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000162	0.000349	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000161	0.000347	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.00016	0.000345	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.00016	0.000345	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000159	0.000343	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000159	0.000343	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000158	0.000341	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000157	0.000339	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000157	0.000338	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000157	0.000337	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000156	0.000337	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000156	0.000336	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000156	0.000336	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000156	0.000335	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000155	0.000335	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000155	0.000334	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000154	0.000333	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000154	0.000331	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000154	0.000331	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000154	0.000331	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000153	0.00033	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000153	0.000328	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000152	0.000328	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000151	0.000325	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—C3—type 2 diabetes mellitus	0.00015	0.000323	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000149	0.000321	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000149	0.000321	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000149	0.00032	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000148	0.000319	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000148	0.000319	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000146	0.000315	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000145	0.000312	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000145	0.000311	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000145	0.000311	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000144	0.00031	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000144	0.000309	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000144	0.000309	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000143	0.000307	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000142	0.000306	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000142	0.000305	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000141	0.000303	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.00014	0.000302	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.00014	0.000302	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.00014	0.000301	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000139	0.0003	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000139	0.000299	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000139	0.000299	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000138	0.000297	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000137	0.000295	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000137	0.000295	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000137	0.000294	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000136	0.000293	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000136	0.000293	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000135	0.000292	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000134	0.00029	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000133	0.000287	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000132	0.000284	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000131	0.000282	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000131	0.000282	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—C3—type 2 diabetes mellitus	0.000128	0.000275	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000128	0.000275	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000127	0.000273	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000127	0.000273	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000126	0.000271	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000125	0.00027	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000125	0.00027	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000125	0.000268	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000125	0.000268	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000123	0.000266	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000123	0.000265	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000123	0.000264	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000122	0.000263	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000122	0.000263	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000122	0.000262	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000121	0.000262	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000119	0.000257	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000119	0.000256	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000119	0.000256	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000118	0.000253	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000117	0.000253	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000117	0.000251	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000115	0.000248	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000115	0.000248	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000114	0.000247	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000114	0.000246	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000112	0.000242	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000109	0.000235	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000108	0.000233	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000108	0.000233	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000107	0.000231	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000107	0.00023	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000107	0.00023	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000106	0.000229	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000106	0.000229	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000106	0.000228	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000106	0.000228	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000106	0.000228	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000105	0.000227	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000105	0.000226	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000105	0.000225	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000104	0.000224	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000103	0.000222	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000103	0.000221	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000102	0.00022	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000102	0.000219	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—INS—type 2 diabetes mellitus	0.000102	0.000219	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000101	0.000218	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000101	0.000217	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.0001	0.000215	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—LPL—type 2 diabetes mellitus	9.84e-05	0.000212	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.84e-05	0.000212	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.83e-05	0.000212	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.79e-05	0.000211	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—LPL—type 2 diabetes mellitus	9.77e-05	0.00021	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.64e-05	0.000207	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.57e-05	0.000206	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.34e-05	0.000201	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.24e-05	0.000199	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.17e-05	0.000197	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.07e-05	0.000195	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCR5—type 2 diabetes mellitus	9e-05	0.000194	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.92e-05	0.000192	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.92e-05	0.000192	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—C3—type 2 diabetes mellitus	8.86e-05	0.000191	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—C3—type 2 diabetes mellitus	8.8e-05	0.000189	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.45e-05	0.000182	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.43e-05	0.000182	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AGT—type 2 diabetes mellitus	8.42e-05	0.000181	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RELA—type 2 diabetes mellitus	8.39e-05	0.000181	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.39e-05	0.000181	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.37e-05	0.00018	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AGT—type 2 diabetes mellitus	8.36e-05	0.00018	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.28e-05	0.000178	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	8.25e-05	0.000178	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	8.25e-05	0.000178	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.22e-05	0.000177	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—LEP—type 2 diabetes mellitus	8.19e-05	0.000176	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APOE—type 2 diabetes mellitus	8.19e-05	0.000176	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.16e-05	0.000176	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.1e-05	0.000174	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.78e-05	0.000168	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.72e-05	0.000166	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.64e-05	0.000165	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.57e-05	0.000163	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.52e-05	0.000162	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.36e-05	0.000158	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.31e-05	0.000157	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.15e-05	0.000154	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.08e-05	0.000152	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—INS—type 2 diabetes mellitus	7.05e-05	0.000152	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—INS—type 2 diabetes mellitus	7e-05	0.000151	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.94e-05	0.000149	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.93e-05	0.000149	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.89e-05	0.000148	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.82e-05	0.000147	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.81e-05	0.000147	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.78e-05	0.000146	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.77e-05	0.000146	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.76e-05	0.000146	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.74e-05	0.000145	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	6.6e-05	0.000142	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.47e-05	0.000139	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.43e-05	0.000138	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.42e-05	0.000138	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.18e-05	0.000133	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.18e-05	0.000133	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.14e-05	0.000132	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.14e-05	0.000132	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.9e-05	0.000127	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.82e-05	0.000125	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.78e-05	0.000124	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RELA—type 2 diabetes mellitus	5.78e-05	0.000124	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.3e-05	0.000114	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.26e-05	0.000113	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.25e-05	0.000113	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.21e-05	0.000112	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.21e-05	0.000112	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.18e-05	0.000111	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.96e-05	0.000107	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.92e-05	0.000106	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.91e-05	0.000106	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.87e-05	0.000105	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.81e-05	0.000104	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.78e-05	0.000103	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.57e-05	9.84e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.54e-05	9.77e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.45e-05	9.59e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	4.44e-05	9.57e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.42e-05	9.52e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.1e-05	8.83e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.09e-05	8.8e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.06e-05	8.74e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.01e-05	8.63e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.98e-05	8.57e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.08e-05	6.63e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.06e-05	6.58e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.84e-05	6.12e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.82e-05	6.07e-05	CbGpPWpGaD
